Shionogi will disclose plain language summaries of clinical trials conducted in patients by Shionogi beginning in April 2020.

This website may include information of products whose development has been discontinued, indication and dosage that have not been reviewed or approved by regulatory agencies, or products approved only in some countries.

Information provided on this website is not intended to promote or advertise Shionogi products.

Please read the Plain Language Summaries after understanding and consenting to the above.

Code No. Indication Study title Study period Plain Language Summaries
S-812217 Major depressive disorder A phase 2 study of S-812217 in patients with major depressive disorder 2020/6~2021/9 EN
S-637880 Neuropathic low back pain A phase 2a study of S-637880 in patients with neuropathic low back pain 2021/3~2021/9 EN